PDE7A and chronic obstructive pulmonary disease: Regarding respiratory diseases, PDE7 inhibitors may have beneficial effects in asthma and COPD due to relaxation of airway smooth muscles and anti-inflammatory properties [67,68], as well as in smoke-induced lung inflammation in mice [69].